___

• Advis, J.P., White, S.S. & Ojeda, S.R. (1981). Activation of growth hormone short loop negative feedback delays puberty in the female rat. Endocrinology. 108(4),1343-1352.
• Beckers, A., Stevenaert, A., Foidart, J.M., Hennen, G. & Frankenne, F. 1990). Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab. 71,725- 731.
• Boulanger, C., Vezzosi, D., Bennet, A., Lorenzini, F., Fauvel, J. & Caron, P. (2004). Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. J Endocrinol Invest. 27(5),465-470.
• Bronstein, M.D., Salgado, L.R. & de Castro Musolino, N.R. (2002) Medical management of pituary adenomas: the special case of management of the pregnant woman. Pituitary 5(2),99-107.
• Caron, P., Broussaud, S., Bertherat, J., Borson-Chazot, F., Brue, T., CortetRudelli, C. & Chanson, P. (2010). Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 95(10),4680-4687.
• Caron, P., Buscail, L., Beckers, A., Esteve, J.P., Igout, A., Hennen, G. & Susini, C. (1997). Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J Clin Endocrinol Metabol. 82(11), 3771–3776.
• Caron, P., Gerbeau, C. & Pradayrol, L. (1995). Maternal–fetal transfer of octreotide. N Eng J Med 333(9),601–602.
• Cheng, S., Grasso, L., Martinez-Orozco, J.A., Al-Agha R., Pivonello, R., Colao, A., et al. (2012). Pregnancy in acromegaly: Experience from two referral centers and systematic review of the literature. Clin Endocrinol (Oxf) 76(2),264-271.
• Cozzi, R., Attanasio, R. & Barausse, M. (2006). Pregnancy in acromegaly: A one-center experience. Eur J Endocrinol. 155(2),279-284. Davidoff, L.M. & Bull, N.Y. (1940) Hyperpituitarism and hypopituitarism. Acad Med 16(4), 227.
• Demura, R., Ono, M., Demura, H., Schizume, D.K. & Oouchi, H. (1982). Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17b-estradiol in the human ovary. JnClin Endocrinol Metab. 54(6), 1246 –1250.
• Fassnacht, M., Capeller, B., Arlt, W., Steck, T. & Allolio, B. (2001). Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol 55(3), 411–415.
• Goluboff, L.G. & Enrin, C. (1969). Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab 29(12), 1533-1538.
• Herman-Bonert, V., Seliverstov, M. & Melmed, S. (1998). Pregnacy in acromegaly: succesfull therapeutic outcome. J Clin Endocrinol Metab 83(3), 727-731.
• Hsu, C.J. & Hammond, J.M. (1987). Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine gramulosa cells. Endocrinology 121(4), 1343–1348.
• Kashyap, R.R., Babu, G.S. & Shetty, S.R. (2011). Dental patient with acromegaly: a case report. J Oral Sci 53(1), 133-36.
• Kupersmith, M.J., Rosenberg, C. & Kleinberg, D. (1994). Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 121(7), 473-477.
• Leandro, K., Leonardo, V.N., Takiya, C. M. & Mônica, R.G. (2012). Growth of an aggressive tumor during pregnancy in anacromegalic patient. Endocr J 59(4), 313-319.
• Lois, K., Bukowczan, J., Perros, P., Jones, S., Gunn, M. & James, R.A. (2014) The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines. Pituitary. Jul 23[ Epub ahead of print].
• Lombardi, G., Di Somma, C., Grasso, L.F., Savanelli, M.C., Colao, A. & Pivonello, R. (2012). The cardiovascular system in growth hormone excess and growth hormone deficiency. J Endocrinol Invest. 35(11), 1021-1029.
• Magyar, D.M. & Marshall, J.R. (1978). Pituitary tumors and pregnancy. Am J Obstet Gynecol 132, 739-751.
• Molitch, M.E. (1985). Pregnancy and hyperprolactinemic women. N Engl J Med. 312(21), 1364–1370.
• Sauder, S.E., Frager, M., Case, G.D., Kelch, R.P. & Marshall, J.C. (1984). Abnormal patterns of pulsalite luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine. J Clin Endocrinol Metab. 59(5), 941-948.
• Schöfl, C., Grussendorf, M., Honegger, J., Tönjes, A., Thyroke-Gronostay, D., Mayr, B.M. & Schopohl, J. (2015) Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey. Eur J Endocrinol. 172(4), 351-356.
• Thoma, K.H. (1950). Oral pathology: a histo¬logical rontgenological and clinical study of diseases of the teeth, jaws and mouth. 4th ed. St. Louis: Mosby,710-714.
• Tonyukuk Gedik, V. (2007). Acromegally: epidemiology, etiology and classification. Turkiye Klinikleri J Int Med Sci. 3(37), 6-8.
• Turkalj, I., Braun, P. & Krupp, P. (1982). Surveillance of bromocriptine in pregnancy. JAMA 247(11), 1589–1591.
• Viollet, C., Bodenant, C., Prunotto, C., Roosterman, D., Schaefer, J., Meyerhof, W., Epelbaum, J., Vaudry, H. & Leroux, P. (1997). Differential expression of multiple somatostatin receptors in the rat cerebellum during development. J Neurochem. 68(6), 2263-2272.
• Winters, J.J. & Troen, P. (1984). Altered pulsatile secretion of lutenizing hormone in hypogonadal men with hyperprolactinemia. Clin Endocrinol (Oxf). 21(3), 257–163.
• Yamamoto, M., Fukuoka, H., Iguchi, G., Matsumoto, R., Takahashi, M., Nishizawa, H., Suda, K., Bando, H. & Takahashi, Y. (2014). The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study. Pituitary. Jun 20 [ Epub ahead of print]